4-(Trifluoromethoxy)benzyl alcohol

We are 4-(Trifluoromethoxy)benzyl alcohol CAS:1736-74-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:4-(Trifluoromethoxy)benzyl alcohol
CAS.NO:1736-74-9
Synonyms:4-(Trifluoromethoxy)benzyl alcohol
[4-(trifluoromethoxy)phenyl]methanol
Molecular Formula:C8H7F3O2
Molecular Weight:192.13500
 
Physical and Chemical Properties:
Density:1.326
Boiling point:108ºC
Flash point:209°F
Index of Refraction:1.449
 
Specification:
Appearance:Light yellow transparent liquid
Assay:≥98.0%
Moisture:≤0.5%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Organic synthesis intermediate

4-(Trifluoromethoxy)benzyl alcohol


Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.23056-33-9 Subsequently, the company launched the drug under the brand names ‘Remo’ and ‘Remozen’.2,8-bis (trifluorometil) -1H-quinolin-4-ona CAS:35853-41-9 Beneficial drug raw materials refer to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs). They are mainly used to meet the needs of original multinational pharmaceutical companies and emerging biopharmaceutical companies for innovative drugs in clinical drug research, registration approval and commercialization sales , Which also contains advanced intermediates used in the manufacture of the drug substance that need to be regulated by regulatory authorities.Acetoacet-p-fenetidida CAS:122-82-7 Rigosertib, Onconova’s lead candidate, is a proprietary Phase 3 small molecule.In a stringent xenograft model of disseminated lymphoblastic leukemia, FT819 demonstrated enhanced tumor clearance and control of leukemia as compared to primary CAR19 T cells.

Related Products
Product Name
4-benzhydryloxy-1-methylpiperidine,hydrochloride View Details
2-Fluoro-3-methylpyridine View Details
4-[2-[2-(4-aminophenoxy)ethyl-methylamino]ethyl]aniline View Details
2,3-dimethylbenzoic acid manufacturer Methyl Acetimidate Hydrochloride manufacturer 5-(2-Fluorophenyl)-1H-pyrrole-3-carboxaldehyde manufacturer 5-bromo-6-methoxypyridin-3-amine manufacturer 2-imino-1,3-dithiolane manufacturer